Global Biopharmaceutical and Vaccines Market Growth (Status and Outlook) 2025-2031
According to this study, the global Biopharmaceutical and Vaccines market size will reach US$ million by 2031.
Biopharmaceuticals and vaccines are well recognized for their potential in treating incurable diseases for which conventional low-molecular-weight pharmaceuticals produced by chemical synthesis are ineffective and for preventing infectious diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Biopharmaceutical and Vaccines Industry Forecast” looks at past sales and reviews total world Biopharmaceutical and Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Biopharmaceutical and Vaccines sales for 2025 through 2031. With Biopharmaceutical and Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biopharmaceutical and Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Biopharmaceutical and Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biopharmaceutical and Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biopharmaceutical and Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biopharmaceutical and Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biopharmaceutical and Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceutical and Vaccines market by product type, application, key players and key regions and countries.
Segmentation by Type:
Biopharmaceuticals and vaccines are well recognized for their potential in treating incurable diseases for which conventional low-molecular-weight pharmaceuticals produced by chemical synthesis are ineffective and for preventing infectious diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Biopharmaceutical and Vaccines Industry Forecast” looks at past sales and reviews total world Biopharmaceutical and Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Biopharmaceutical and Vaccines sales for 2025 through 2031. With Biopharmaceutical and Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biopharmaceutical and Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Biopharmaceutical and Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biopharmaceutical and Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biopharmaceutical and Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biopharmaceutical and Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biopharmaceutical and Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceutical and Vaccines market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Biopharmaceutical
- Vaccine Production
- Pharmaceuticals Industry
- Clinical Diagnosis
- Scientific Research
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Pfizer
- Sanofi
- Roche
- Abbott
- Biogen Idec
- Regeneron Pharmaceuticals
- Alexion Pharmaceuticals
- Johnson and Johnson
- GlaxoSmithKline
- Merck
- Lonza
- Boehringer Ingelheim
- Rentschler
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biopharmaceutical and Vaccines Market Size (2020-2031)
2.1.2 Biopharmaceutical and Vaccines Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Biopharmaceutical and Vaccines by Country/Region (2020, 2024 & 2031)
2.2 Biopharmaceutical and Vaccines Segment by Type
2.2.1 Biopharmaceutical
2.2.2 Vaccine Production
2.3 Biopharmaceutical and Vaccines Market Size by Type
2.3.1 Biopharmaceutical and Vaccines Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Biopharmaceutical and Vaccines Market Size Market Share by Type (2020-2025)
2.4 Biopharmaceutical and Vaccines Segment by Application
2.4.1 Pharmaceuticals Industry
2.4.2 Clinical Diagnosis
2.4.3 Scientific Research
2.4.4 Others
2.5 Biopharmaceutical and Vaccines Market Size by Application
2.5.1 Biopharmaceutical and Vaccines Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Biopharmaceutical and Vaccines Market Size Market Share by Application (2020-2025)
3 BIOPHARMACEUTICAL AND VACCINES MARKET SIZE BY PLAYER
3.1 Biopharmaceutical and Vaccines Market Size Market Share by Player
3.1.1 Global Biopharmaceutical and Vaccines Revenue by Player (2020-2025)
3.1.2 Global Biopharmaceutical and Vaccines Revenue Market Share by Player (2020-2025)
3.2 Global Biopharmaceutical and Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOPHARMACEUTICAL AND VACCINES BY REGION
4.1 Biopharmaceutical and Vaccines Market Size by Region (2020-2025)
4.2 Global Biopharmaceutical and Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Biopharmaceutical and Vaccines Market Size Growth (2020-2025)
4.4 APAC Biopharmaceutical and Vaccines Market Size Growth (2020-2025)
4.5 Europe Biopharmaceutical and Vaccines Market Size Growth (2020-2025)
4.6 Middle East & Africa Biopharmaceutical and Vaccines Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Biopharmaceutical and Vaccines Market Size by Country (2020-2025)
5.2 Americas Biopharmaceutical and Vaccines Market Size by Type (2020-2025)
5.3 Americas Biopharmaceutical and Vaccines Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biopharmaceutical and Vaccines Market Size by Region (2020-2025)
6.2 APAC Biopharmaceutical and Vaccines Market Size by Type (2020-2025)
6.3 APAC Biopharmaceutical and Vaccines Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biopharmaceutical and Vaccines Market Size by Country (2020-2025)
7.2 Europe Biopharmaceutical and Vaccines Market Size by Type (2020-2025)
7.3 Europe Biopharmaceutical and Vaccines Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biopharmaceutical and Vaccines by Region (2020-2025)
8.2 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Type (2020-2025)
8.3 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOPHARMACEUTICAL AND VACCINES MARKET FORECAST
10.1 Global Biopharmaceutical and Vaccines Forecast by Region (2026-2031)
10.1.1 Global Biopharmaceutical and Vaccines Forecast by Region (2026-2031)
10.1.2 Americas Biopharmaceutical and Vaccines Forecast
10.1.3 APAC Biopharmaceutical and Vaccines Forecast
10.1.4 Europe Biopharmaceutical and Vaccines Forecast
10.1.5 Middle East & Africa Biopharmaceutical and Vaccines Forecast
10.2 Americas Biopharmaceutical and Vaccines Forecast by Country (2026-2031)
10.2.1 United States Market Biopharmaceutical and Vaccines Forecast
10.2.2 Canada Market Biopharmaceutical and Vaccines Forecast
10.2.3 Mexico Market Biopharmaceutical and Vaccines Forecast
10.2.4 Brazil Market Biopharmaceutical and Vaccines Forecast
10.3 APAC Biopharmaceutical and Vaccines Forecast by Region (2026-2031)
10.3.1 China Biopharmaceutical and Vaccines Market Forecast
10.3.2 Japan Market Biopharmaceutical and Vaccines Forecast
10.3.3 Korea Market Biopharmaceutical and Vaccines Forecast
10.3.4 Southeast Asia Market Biopharmaceutical and Vaccines Forecast
10.3.5 India Market Biopharmaceutical and Vaccines Forecast
10.3.6 Australia Market Biopharmaceutical and Vaccines Forecast
10.4 Europe Biopharmaceutical and Vaccines Forecast by Country (2026-2031)
10.4.1 Germany Market Biopharmaceutical and Vaccines Forecast
10.4.2 France Market Biopharmaceutical and Vaccines Forecast
10.4.3 UK Market Biopharmaceutical and Vaccines Forecast
10.4.4 Italy Market Biopharmaceutical and Vaccines Forecast
10.4.5 Russia Market Biopharmaceutical and Vaccines Forecast
10.5 Middle East & Africa Biopharmaceutical and Vaccines Forecast by Region (2026-2031)
10.5.1 Egypt Market Biopharmaceutical and Vaccines Forecast
10.5.2 South Africa Market Biopharmaceutical and Vaccines Forecast
10.5.3 Israel Market Biopharmaceutical and Vaccines Forecast
10.5.4 Turkey Market Biopharmaceutical and Vaccines Forecast
10.6 Global Biopharmaceutical and Vaccines Forecast by Type (2026-2031)
10.7 Global Biopharmaceutical and Vaccines Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Biopharmaceutical and Vaccines Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Biopharmaceutical and Vaccines Product Offered
11.1.3 Novartis Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Biopharmaceutical and Vaccines Product Offered
11.2.3 Pfizer Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Biopharmaceutical and Vaccines Product Offered
11.3.3 Sanofi Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Sanofi Main Business Overview
11.3.5 Sanofi Latest Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Biopharmaceutical and Vaccines Product Offered
11.4.3 Roche Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Roche Main Business Overview
11.4.5 Roche Latest Developments
11.5 Abbott
11.5.1 Abbott Company Information
11.5.2 Abbott Biopharmaceutical and Vaccines Product Offered
11.5.3 Abbott Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Abbott Main Business Overview
11.5.5 Abbott Latest Developments
11.6 Biogen Idec
11.6.1 Biogen Idec Company Information
11.6.2 Biogen Idec Biopharmaceutical and Vaccines Product Offered
11.6.3 Biogen Idec Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Biogen Idec Main Business Overview
11.6.5 Biogen Idec Latest Developments
11.7 Regeneron Pharmaceuticals
11.7.1 Regeneron Pharmaceuticals Company Information
11.7.2 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Product Offered
11.7.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Regeneron Pharmaceuticals Main Business Overview
11.7.5 Regeneron Pharmaceuticals Latest Developments
11.8 Alexion Pharmaceuticals
11.8.1 Alexion Pharmaceuticals Company Information
11.8.2 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Product Offered
11.8.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Alexion Pharmaceuticals Main Business Overview
11.8.5 Alexion Pharmaceuticals Latest Developments
11.9 Johnson and Johnson
11.9.1 Johnson and Johnson Company Information
11.9.2 Johnson and Johnson Biopharmaceutical and Vaccines Product Offered
11.9.3 Johnson and Johnson Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Johnson and Johnson Main Business Overview
11.9.5 Johnson and Johnson Latest Developments
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Information
11.10.2 GlaxoSmithKline Biopharmaceutical and Vaccines Product Offered
11.10.3 GlaxoSmithKline Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 GlaxoSmithKline Main Business Overview
11.10.5 GlaxoSmithKline Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Biopharmaceutical and Vaccines Product Offered
11.11.3 Merck Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 Lonza
11.12.1 Lonza Company Information
11.12.2 Lonza Biopharmaceutical and Vaccines Product Offered
11.12.3 Lonza Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Lonza Main Business Overview
11.12.5 Lonza Latest Developments
11.13 Boehringer Ingelheim
11.13.1 Boehringer Ingelheim Company Information
11.13.2 Boehringer Ingelheim Biopharmaceutical and Vaccines Product Offered
11.13.3 Boehringer Ingelheim Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Boehringer Ingelheim Main Business Overview
11.13.5 Boehringer Ingelheim Latest Developments
11.14 Rentschler
11.14.1 Rentschler Company Information
11.14.2 Rentschler Biopharmaceutical and Vaccines Product Offered
11.14.3 Rentschler Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Rentschler Main Business Overview
11.14.5 Rentschler Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biopharmaceutical and Vaccines Market Size (2020-2031)
2.1.2 Biopharmaceutical and Vaccines Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Biopharmaceutical and Vaccines by Country/Region (2020, 2024 & 2031)
2.2 Biopharmaceutical and Vaccines Segment by Type
2.2.1 Biopharmaceutical
2.2.2 Vaccine Production
2.3 Biopharmaceutical and Vaccines Market Size by Type
2.3.1 Biopharmaceutical and Vaccines Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Biopharmaceutical and Vaccines Market Size Market Share by Type (2020-2025)
2.4 Biopharmaceutical and Vaccines Segment by Application
2.4.1 Pharmaceuticals Industry
2.4.2 Clinical Diagnosis
2.4.3 Scientific Research
2.4.4 Others
2.5 Biopharmaceutical and Vaccines Market Size by Application
2.5.1 Biopharmaceutical and Vaccines Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Biopharmaceutical and Vaccines Market Size Market Share by Application (2020-2025)
3 BIOPHARMACEUTICAL AND VACCINES MARKET SIZE BY PLAYER
3.1 Biopharmaceutical and Vaccines Market Size Market Share by Player
3.1.1 Global Biopharmaceutical and Vaccines Revenue by Player (2020-2025)
3.1.2 Global Biopharmaceutical and Vaccines Revenue Market Share by Player (2020-2025)
3.2 Global Biopharmaceutical and Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOPHARMACEUTICAL AND VACCINES BY REGION
4.1 Biopharmaceutical and Vaccines Market Size by Region (2020-2025)
4.2 Global Biopharmaceutical and Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Biopharmaceutical and Vaccines Market Size Growth (2020-2025)
4.4 APAC Biopharmaceutical and Vaccines Market Size Growth (2020-2025)
4.5 Europe Biopharmaceutical and Vaccines Market Size Growth (2020-2025)
4.6 Middle East & Africa Biopharmaceutical and Vaccines Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Biopharmaceutical and Vaccines Market Size by Country (2020-2025)
5.2 Americas Biopharmaceutical and Vaccines Market Size by Type (2020-2025)
5.3 Americas Biopharmaceutical and Vaccines Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biopharmaceutical and Vaccines Market Size by Region (2020-2025)
6.2 APAC Biopharmaceutical and Vaccines Market Size by Type (2020-2025)
6.3 APAC Biopharmaceutical and Vaccines Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biopharmaceutical and Vaccines Market Size by Country (2020-2025)
7.2 Europe Biopharmaceutical and Vaccines Market Size by Type (2020-2025)
7.3 Europe Biopharmaceutical and Vaccines Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biopharmaceutical and Vaccines by Region (2020-2025)
8.2 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Type (2020-2025)
8.3 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOPHARMACEUTICAL AND VACCINES MARKET FORECAST
10.1 Global Biopharmaceutical and Vaccines Forecast by Region (2026-2031)
10.1.1 Global Biopharmaceutical and Vaccines Forecast by Region (2026-2031)
10.1.2 Americas Biopharmaceutical and Vaccines Forecast
10.1.3 APAC Biopharmaceutical and Vaccines Forecast
10.1.4 Europe Biopharmaceutical and Vaccines Forecast
10.1.5 Middle East & Africa Biopharmaceutical and Vaccines Forecast
10.2 Americas Biopharmaceutical and Vaccines Forecast by Country (2026-2031)
10.2.1 United States Market Biopharmaceutical and Vaccines Forecast
10.2.2 Canada Market Biopharmaceutical and Vaccines Forecast
10.2.3 Mexico Market Biopharmaceutical and Vaccines Forecast
10.2.4 Brazil Market Biopharmaceutical and Vaccines Forecast
10.3 APAC Biopharmaceutical and Vaccines Forecast by Region (2026-2031)
10.3.1 China Biopharmaceutical and Vaccines Market Forecast
10.3.2 Japan Market Biopharmaceutical and Vaccines Forecast
10.3.3 Korea Market Biopharmaceutical and Vaccines Forecast
10.3.4 Southeast Asia Market Biopharmaceutical and Vaccines Forecast
10.3.5 India Market Biopharmaceutical and Vaccines Forecast
10.3.6 Australia Market Biopharmaceutical and Vaccines Forecast
10.4 Europe Biopharmaceutical and Vaccines Forecast by Country (2026-2031)
10.4.1 Germany Market Biopharmaceutical and Vaccines Forecast
10.4.2 France Market Biopharmaceutical and Vaccines Forecast
10.4.3 UK Market Biopharmaceutical and Vaccines Forecast
10.4.4 Italy Market Biopharmaceutical and Vaccines Forecast
10.4.5 Russia Market Biopharmaceutical and Vaccines Forecast
10.5 Middle East & Africa Biopharmaceutical and Vaccines Forecast by Region (2026-2031)
10.5.1 Egypt Market Biopharmaceutical and Vaccines Forecast
10.5.2 South Africa Market Biopharmaceutical and Vaccines Forecast
10.5.3 Israel Market Biopharmaceutical and Vaccines Forecast
10.5.4 Turkey Market Biopharmaceutical and Vaccines Forecast
10.6 Global Biopharmaceutical and Vaccines Forecast by Type (2026-2031)
10.7 Global Biopharmaceutical and Vaccines Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Biopharmaceutical and Vaccines Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Biopharmaceutical and Vaccines Product Offered
11.1.3 Novartis Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Biopharmaceutical and Vaccines Product Offered
11.2.3 Pfizer Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Biopharmaceutical and Vaccines Product Offered
11.3.3 Sanofi Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Sanofi Main Business Overview
11.3.5 Sanofi Latest Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Biopharmaceutical and Vaccines Product Offered
11.4.3 Roche Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Roche Main Business Overview
11.4.5 Roche Latest Developments
11.5 Abbott
11.5.1 Abbott Company Information
11.5.2 Abbott Biopharmaceutical and Vaccines Product Offered
11.5.3 Abbott Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Abbott Main Business Overview
11.5.5 Abbott Latest Developments
11.6 Biogen Idec
11.6.1 Biogen Idec Company Information
11.6.2 Biogen Idec Biopharmaceutical and Vaccines Product Offered
11.6.3 Biogen Idec Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Biogen Idec Main Business Overview
11.6.5 Biogen Idec Latest Developments
11.7 Regeneron Pharmaceuticals
11.7.1 Regeneron Pharmaceuticals Company Information
11.7.2 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Product Offered
11.7.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Regeneron Pharmaceuticals Main Business Overview
11.7.5 Regeneron Pharmaceuticals Latest Developments
11.8 Alexion Pharmaceuticals
11.8.1 Alexion Pharmaceuticals Company Information
11.8.2 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Product Offered
11.8.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Alexion Pharmaceuticals Main Business Overview
11.8.5 Alexion Pharmaceuticals Latest Developments
11.9 Johnson and Johnson
11.9.1 Johnson and Johnson Company Information
11.9.2 Johnson and Johnson Biopharmaceutical and Vaccines Product Offered
11.9.3 Johnson and Johnson Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Johnson and Johnson Main Business Overview
11.9.5 Johnson and Johnson Latest Developments
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Information
11.10.2 GlaxoSmithKline Biopharmaceutical and Vaccines Product Offered
11.10.3 GlaxoSmithKline Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 GlaxoSmithKline Main Business Overview
11.10.5 GlaxoSmithKline Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Biopharmaceutical and Vaccines Product Offered
11.11.3 Merck Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 Lonza
11.12.1 Lonza Company Information
11.12.2 Lonza Biopharmaceutical and Vaccines Product Offered
11.12.3 Lonza Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Lonza Main Business Overview
11.12.5 Lonza Latest Developments
11.13 Boehringer Ingelheim
11.13.1 Boehringer Ingelheim Company Information
11.13.2 Boehringer Ingelheim Biopharmaceutical and Vaccines Product Offered
11.13.3 Boehringer Ingelheim Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Boehringer Ingelheim Main Business Overview
11.13.5 Boehringer Ingelheim Latest Developments
11.14 Rentschler
11.14.1 Rentschler Company Information
11.14.2 Rentschler Biopharmaceutical and Vaccines Product Offered
11.14.3 Rentschler Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Rentschler Main Business Overview
11.14.5 Rentschler Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biopharmaceutical and Vaccines Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Biopharmaceutical and Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Biopharmaceutical
Table 4. Major Players of Vaccine Production
Table 5. Biopharmaceutical and Vaccines Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Biopharmaceutical and Vaccines Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Biopharmaceutical and Vaccines Market Size Market Share by Type (2020-2025)
Table 8. Biopharmaceutical and Vaccines Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Biopharmaceutical and Vaccines Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Biopharmaceutical and Vaccines Market Size Market Share by Application (2020-2025)
Table 11. Global Biopharmaceutical and Vaccines Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Biopharmaceutical and Vaccines Revenue Market Share by Player (2020-2025)
Table 13. Biopharmaceutical and Vaccines Key Players Head office and Products Offered
Table 14. Biopharmaceutical and Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Biopharmaceutical and Vaccines Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Biopharmaceutical and Vaccines Market Size Market Share by Region (2020-2025)
Table 19. Global Biopharmaceutical and Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Biopharmaceutical and Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Biopharmaceutical and Vaccines Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Biopharmaceutical and Vaccines Market Size Market Share by Country (2020-2025)
Table 23. Americas Biopharmaceutical and Vaccines Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Biopharmaceutical and Vaccines Market Size Market Share by Type (2020-2025)
Table 25. Americas Biopharmaceutical and Vaccines Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Biopharmaceutical and Vaccines Market Size Market Share by Application (2020-2025)
Table 27. APAC Biopharmaceutical and Vaccines Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Biopharmaceutical and Vaccines Market Size Market Share by Region (2020-2025)
Table 29. APAC Biopharmaceutical and Vaccines Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Biopharmaceutical and Vaccines Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Biopharmaceutical and Vaccines Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Biopharmaceutical and Vaccines Market Size Market Share by Country (2020-2025)
Table 33. Europe Biopharmaceutical and Vaccines Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Biopharmaceutical and Vaccines Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Biopharmaceutical and Vaccines Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Biopharmaceutical and Vaccines Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Biopharmaceutical and Vaccines Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Biopharmaceutical and Vaccines
Table 39. Key Market Challenges & Risks of Biopharmaceutical and Vaccines
Table 40. Key Industry Trends of Biopharmaceutical and Vaccines
Table 41. Global Biopharmaceutical and Vaccines Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Biopharmaceutical and Vaccines Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Biopharmaceutical and Vaccines Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Biopharmaceutical and Vaccines Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Novartis Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 46. Novartis Biopharmaceutical and Vaccines Product Offered
Table 47. Novartis Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Novartis Main Business
Table 49. Novartis Latest Developments
Table 50. Pfizer Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 51. Pfizer Biopharmaceutical and Vaccines Product Offered
Table 52. Pfizer Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Pfizer Main Business
Table 54. Pfizer Latest Developments
Table 55. Sanofi Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 56. Sanofi Biopharmaceutical and Vaccines Product Offered
Table 57. Sanofi Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Sanofi Main Business
Table 59. Sanofi Latest Developments
Table 60. Roche Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 61. Roche Biopharmaceutical and Vaccines Product Offered
Table 62. Roche Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Roche Main Business
Table 64. Roche Latest Developments
Table 65. Abbott Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 66. Abbott Biopharmaceutical and Vaccines Product Offered
Table 67. Abbott Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Abbott Main Business
Table 69. Abbott Latest Developments
Table 70. Biogen Idec Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 71. Biogen Idec Biopharmaceutical and Vaccines Product Offered
Table 72. Biogen Idec Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Biogen Idec Main Business
Table 74. Biogen Idec Latest Developments
Table 75. Regeneron Pharmaceuticals Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 76. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Product Offered
Table 77. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Regeneron Pharmaceuticals Main Business
Table 79. Regeneron Pharmaceuticals Latest Developments
Table 80. Alexion Pharmaceuticals Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 81. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Product Offered
Table 82. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Alexion Pharmaceuticals Main Business
Table 84. Alexion Pharmaceuticals Latest Developments
Table 85. Johnson and Johnson Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 86. Johnson and Johnson Biopharmaceutical and Vaccines Product Offered
Table 87. Johnson and Johnson Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Johnson and Johnson Main Business
Table 89. Johnson and Johnson Latest Developments
Table 90. GlaxoSmithKline Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 91. GlaxoSmithKline Biopharmaceutical and Vaccines Product Offered
Table 92. GlaxoSmithKline Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. GlaxoSmithKline Main Business
Table 94. GlaxoSmithKline Latest Developments
Table 95. Merck Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 96. Merck Biopharmaceutical and Vaccines Product Offered
Table 97. Merck Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Merck Main Business
Table 99. Merck Latest Developments
Table 100. Lonza Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 101. Lonza Biopharmaceutical and Vaccines Product Offered
Table 102. Lonza Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Lonza Main Business
Table 104. Lonza Latest Developments
Table 105. Boehringer Ingelheim Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 106. Boehringer Ingelheim Biopharmaceutical and Vaccines Product Offered
Table 107. Boehringer Ingelheim Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Boehringer Ingelheim Main Business
Table 109. Boehringer Ingelheim Latest Developments
Table 110. Rentschler Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 111. Rentschler Biopharmaceutical and Vaccines Product Offered
Table 112. Rentschler Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Rentschler Main Business
Table 114. Rentschler Latest Developments
Table 1. Biopharmaceutical and Vaccines Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Biopharmaceutical and Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Biopharmaceutical
Table 4. Major Players of Vaccine Production
Table 5. Biopharmaceutical and Vaccines Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Biopharmaceutical and Vaccines Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Biopharmaceutical and Vaccines Market Size Market Share by Type (2020-2025)
Table 8. Biopharmaceutical and Vaccines Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Biopharmaceutical and Vaccines Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Biopharmaceutical and Vaccines Market Size Market Share by Application (2020-2025)
Table 11. Global Biopharmaceutical and Vaccines Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Biopharmaceutical and Vaccines Revenue Market Share by Player (2020-2025)
Table 13. Biopharmaceutical and Vaccines Key Players Head office and Products Offered
Table 14. Biopharmaceutical and Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Biopharmaceutical and Vaccines Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Biopharmaceutical and Vaccines Market Size Market Share by Region (2020-2025)
Table 19. Global Biopharmaceutical and Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Biopharmaceutical and Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Biopharmaceutical and Vaccines Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Biopharmaceutical and Vaccines Market Size Market Share by Country (2020-2025)
Table 23. Americas Biopharmaceutical and Vaccines Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Biopharmaceutical and Vaccines Market Size Market Share by Type (2020-2025)
Table 25. Americas Biopharmaceutical and Vaccines Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Biopharmaceutical and Vaccines Market Size Market Share by Application (2020-2025)
Table 27. APAC Biopharmaceutical and Vaccines Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Biopharmaceutical and Vaccines Market Size Market Share by Region (2020-2025)
Table 29. APAC Biopharmaceutical and Vaccines Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Biopharmaceutical and Vaccines Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Biopharmaceutical and Vaccines Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Biopharmaceutical and Vaccines Market Size Market Share by Country (2020-2025)
Table 33. Europe Biopharmaceutical and Vaccines Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Biopharmaceutical and Vaccines Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Biopharmaceutical and Vaccines Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Biopharmaceutical and Vaccines Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Biopharmaceutical and Vaccines Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Biopharmaceutical and Vaccines
Table 39. Key Market Challenges & Risks of Biopharmaceutical and Vaccines
Table 40. Key Industry Trends of Biopharmaceutical and Vaccines
Table 41. Global Biopharmaceutical and Vaccines Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Biopharmaceutical and Vaccines Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Biopharmaceutical and Vaccines Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Biopharmaceutical and Vaccines Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Novartis Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 46. Novartis Biopharmaceutical and Vaccines Product Offered
Table 47. Novartis Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Novartis Main Business
Table 49. Novartis Latest Developments
Table 50. Pfizer Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 51. Pfizer Biopharmaceutical and Vaccines Product Offered
Table 52. Pfizer Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Pfizer Main Business
Table 54. Pfizer Latest Developments
Table 55. Sanofi Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 56. Sanofi Biopharmaceutical and Vaccines Product Offered
Table 57. Sanofi Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Sanofi Main Business
Table 59. Sanofi Latest Developments
Table 60. Roche Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 61. Roche Biopharmaceutical and Vaccines Product Offered
Table 62. Roche Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Roche Main Business
Table 64. Roche Latest Developments
Table 65. Abbott Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 66. Abbott Biopharmaceutical and Vaccines Product Offered
Table 67. Abbott Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Abbott Main Business
Table 69. Abbott Latest Developments
Table 70. Biogen Idec Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 71. Biogen Idec Biopharmaceutical and Vaccines Product Offered
Table 72. Biogen Idec Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Biogen Idec Main Business
Table 74. Biogen Idec Latest Developments
Table 75. Regeneron Pharmaceuticals Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 76. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Product Offered
Table 77. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Regeneron Pharmaceuticals Main Business
Table 79. Regeneron Pharmaceuticals Latest Developments
Table 80. Alexion Pharmaceuticals Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 81. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Product Offered
Table 82. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Alexion Pharmaceuticals Main Business
Table 84. Alexion Pharmaceuticals Latest Developments
Table 85. Johnson and Johnson Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 86. Johnson and Johnson Biopharmaceutical and Vaccines Product Offered
Table 87. Johnson and Johnson Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Johnson and Johnson Main Business
Table 89. Johnson and Johnson Latest Developments
Table 90. GlaxoSmithKline Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 91. GlaxoSmithKline Biopharmaceutical and Vaccines Product Offered
Table 92. GlaxoSmithKline Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. GlaxoSmithKline Main Business
Table 94. GlaxoSmithKline Latest Developments
Table 95. Merck Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 96. Merck Biopharmaceutical and Vaccines Product Offered
Table 97. Merck Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Merck Main Business
Table 99. Merck Latest Developments
Table 100. Lonza Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 101. Lonza Biopharmaceutical and Vaccines Product Offered
Table 102. Lonza Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Lonza Main Business
Table 104. Lonza Latest Developments
Table 105. Boehringer Ingelheim Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 106. Boehringer Ingelheim Biopharmaceutical and Vaccines Product Offered
Table 107. Boehringer Ingelheim Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Boehringer Ingelheim Main Business
Table 109. Boehringer Ingelheim Latest Developments
Table 110. Rentschler Details, Company Type, Biopharmaceutical and Vaccines Area Served and Its Competitors
Table 111. Rentschler Biopharmaceutical and Vaccines Product Offered
Table 112. Rentschler Biopharmaceutical and Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Rentschler Main Business
Table 114. Rentschler Latest Developments
LIST OF FIGURES
Figure 1. Biopharmaceutical and Vaccines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biopharmaceutical and Vaccines Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Biopharmaceutical and Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Biopharmaceutical and Vaccines Sales Market Share by Country/Region (2024)
Figure 8. Biopharmaceutical and Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Biopharmaceutical and Vaccines Market Size Market Share by Type in 2024
Figure 10. Biopharmaceutical and Vaccines in Pharmaceuticals Industry
Figure 11. Global Biopharmaceutical and Vaccines Market: Pharmaceuticals Industry (2020-2025) & ($ millions)
Figure 12. Biopharmaceutical and Vaccines in Clinical Diagnosis
Figure 13. Global Biopharmaceutical and Vaccines Market: Clinical Diagnosis (2020-2025) & ($ millions)
Figure 14. Biopharmaceutical and Vaccines in Scientific Research
Figure 15. Global Biopharmaceutical and Vaccines Market: Scientific Research (2020-2025) & ($ millions)
Figure 16. Biopharmaceutical and Vaccines in Others
Figure 17. Global Biopharmaceutical and Vaccines Market: Others (2020-2025) & ($ millions)
Figure 18. Global Biopharmaceutical and Vaccines Market Size Market Share by Application in 2024
Figure 19. Global Biopharmaceutical and Vaccines Revenue Market Share by Player in 2024
Figure 20. Global Biopharmaceutical and Vaccines Market Size Market Share by Region (2020-2025)
Figure 21. Americas Biopharmaceutical and Vaccines Market Size 2020-2025 ($ millions)
Figure 22. APAC Biopharmaceutical and Vaccines Market Size 2020-2025 ($ millions)
Figure 23. Europe Biopharmaceutical and Vaccines Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Biopharmaceutical and Vaccines Market Size 2020-2025 ($ millions)
Figure 25. Americas Biopharmaceutical and Vaccines Value Market Share by Country in 2024
Figure 26. United States Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Biopharmaceutical and Vaccines Market Size Market Share by Region in 2024
Figure 31. APAC Biopharmaceutical and Vaccines Market Size Market Share by Type (2020-2025)
Figure 32. APAC Biopharmaceutical and Vaccines Market Size Market Share by Application (2020-2025)
Figure 33. China Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 37. India Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Biopharmaceutical and Vaccines Market Size Market Share by Country in 2024
Figure 40. Europe Biopharmaceutical and Vaccines Market Size Market Share by Type (2020-2025)
Figure 41. Europe Biopharmaceutical and Vaccines Market Size Market Share by Application (2020-2025)
Figure 42. Germany Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 43. France Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Biopharmaceutical and Vaccines Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Biopharmaceutical and Vaccines Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Biopharmaceutical and Vaccines Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 56. APAC Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 57. Europe Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 59. United States Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 60. Canada Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 61. Mexico Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 62. Brazil Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 63. China Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 64. Japan Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 65. Korea Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 67. India Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 68. Australia Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 69. Germany Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 70. France Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 71. UK Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 72. Italy Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 73. Russia Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 74. Egypt Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 75. South Africa Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 76. Israel Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 77. Turkey Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 78. Global Biopharmaceutical and Vaccines Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Biopharmaceutical and Vaccines Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 1. Biopharmaceutical and Vaccines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biopharmaceutical and Vaccines Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Biopharmaceutical and Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Biopharmaceutical and Vaccines Sales Market Share by Country/Region (2024)
Figure 8. Biopharmaceutical and Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Biopharmaceutical and Vaccines Market Size Market Share by Type in 2024
Figure 10. Biopharmaceutical and Vaccines in Pharmaceuticals Industry
Figure 11. Global Biopharmaceutical and Vaccines Market: Pharmaceuticals Industry (2020-2025) & ($ millions)
Figure 12. Biopharmaceutical and Vaccines in Clinical Diagnosis
Figure 13. Global Biopharmaceutical and Vaccines Market: Clinical Diagnosis (2020-2025) & ($ millions)
Figure 14. Biopharmaceutical and Vaccines in Scientific Research
Figure 15. Global Biopharmaceutical and Vaccines Market: Scientific Research (2020-2025) & ($ millions)
Figure 16. Biopharmaceutical and Vaccines in Others
Figure 17. Global Biopharmaceutical and Vaccines Market: Others (2020-2025) & ($ millions)
Figure 18. Global Biopharmaceutical and Vaccines Market Size Market Share by Application in 2024
Figure 19. Global Biopharmaceutical and Vaccines Revenue Market Share by Player in 2024
Figure 20. Global Biopharmaceutical and Vaccines Market Size Market Share by Region (2020-2025)
Figure 21. Americas Biopharmaceutical and Vaccines Market Size 2020-2025 ($ millions)
Figure 22. APAC Biopharmaceutical and Vaccines Market Size 2020-2025 ($ millions)
Figure 23. Europe Biopharmaceutical and Vaccines Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Biopharmaceutical and Vaccines Market Size 2020-2025 ($ millions)
Figure 25. Americas Biopharmaceutical and Vaccines Value Market Share by Country in 2024
Figure 26. United States Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Biopharmaceutical and Vaccines Market Size Market Share by Region in 2024
Figure 31. APAC Biopharmaceutical and Vaccines Market Size Market Share by Type (2020-2025)
Figure 32. APAC Biopharmaceutical and Vaccines Market Size Market Share by Application (2020-2025)
Figure 33. China Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 37. India Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Biopharmaceutical and Vaccines Market Size Market Share by Country in 2024
Figure 40. Europe Biopharmaceutical and Vaccines Market Size Market Share by Type (2020-2025)
Figure 41. Europe Biopharmaceutical and Vaccines Market Size Market Share by Application (2020-2025)
Figure 42. Germany Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 43. France Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Biopharmaceutical and Vaccines Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Biopharmaceutical and Vaccines Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Biopharmaceutical and Vaccines Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Biopharmaceutical and Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 56. APAC Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 57. Europe Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 59. United States Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 60. Canada Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 61. Mexico Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 62. Brazil Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 63. China Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 64. Japan Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 65. Korea Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 67. India Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 68. Australia Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 69. Germany Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 70. France Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 71. UK Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 72. Italy Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 73. Russia Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 74. Egypt Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 75. South Africa Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 76. Israel Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 77. Turkey Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
Figure 78. Global Biopharmaceutical and Vaccines Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Biopharmaceutical and Vaccines Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Biopharmaceutical and Vaccines Market Size 2026-2031 ($ millions)
More Publications
Global Prednisolone Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
116 pages
Global Skin Ulcers Anti-Infectives Market Growth 2024-2030
US$ 3,660.00
March 2024
121 pages
